Related Experiment Video

Updated: Jul 11, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Treatment of pediatric HIV infection

Elisa A d'Oulx1, Elena Chiappini, Maurizio de Martino

  • 1Department of Paediatrics, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.

Current Infectious Disease Reports
|September 21, 2007
PubMed

Insights

Pediatric HIV management differs from adults, with updated guidelines recommending triple-drug antiretroviral therapy. Expert care and adherence are crucial for children and adolescents with HIV.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Management of pediatric HIV infection presents unique challenges compared to adults.
  • Antiretroviral therapy (ART) is adapted for children, but critical questions remain, including optimal timing for initiating therapy in asymptomatic cases.
  • Recent updates in treatment guidelines necessitate a review of current pediatric HIV management strategies.

Purpose of the Study:

  • To compare recent international guidelines for the treatment of HIV in children.
  • To review the latest research on pediatric and adolescent HIV management.
  • To provide an overview of current recommended antiretroviral regimens for pediatric HIV.

Main Methods:

  • Comparative analysis of updated pediatric HIV treatment guidelines.
  • Literature review of recent studies on pediatric and adolescent HIV therapy.
  • Synthesis of recommendations for initial and second-line antiretroviral regimens.

Main Results:

  • Triple-drug combination therapy, utilizing either nonnucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors (PIs), is the recommended initial ART for children.
  • For cases of treatment failure, switching between NNRTI- and PI-based regimens is advised for second-line therapy.
  • Management by specialists in pediatric and adolescent HIV infection is emphasized.

Conclusions:

  • Current guidelines support specific triple-drug ART regimens for initial treatment of pediatric HIV.
  • Effective management of treatment failure involves strategic regimen switching.
  • Adherence to antiretroviral therapy is a critical factor for successful outcomes in children and adolescents, especially the latter group.

More Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...